Keyphrases
Natalizumab
100%
Progressive multifocal Leukoencephalopathy
100%
Tertiary Care Hospital
50%
White Matter
50%
Medical History
50%
Neurological Examination
50%
Clinical Course
50%
Older Men
50%
Treatment Duration
50%
Left-handed
50%
Multiple Sclerosis
50%
MRI Abnormalities
50%
Frontoparietal
50%
Fluid-attenuated Inversion Recovery (FLAIR)
50%
Paresthesia
50%
Hyperintensity
50%
Cutaneous T-cell Lymphoma
50%
Clinical MRI
50%
Brain MRI
50%
CHOP Chemotherapy
50%
MRI Findings
50%
Right Arm
50%
Clumsiness
50%
Progressive Development
50%
Natalizumab Treatment
50%
Expressive Aphasia
50%
JCV Serology
50%
Medicine and Dentistry
Progressive Multifocal Leukoencephalopathy
100%
Natalizumab
100%
Magnetic Resonance Imaging
66%
Granulocyte
66%
Arm
33%
Medical History
33%
Disease Course
33%
Patient Referral
33%
Multiple Sclerosis
33%
Neurologic Examination
33%
Cutaneous T Cell Lymphoma
33%
Paresthesia
33%
CHOP
33%
Magnetic Resonance Imaging of Brain
33%
Expressive Aphasia
33%
Neuroscience
Natalizumab
100%
Progressive Multifocal Leukoencephalopathy
100%
Magnetic Resonance Imaging
66%
Polymorphonuclear Cell
66%
Multiple Sclerosis
33%
T Cell
33%
Magnetic Resonance Imaging of Brain
33%
CHOP
33%
Serology
33%
Expressive Aphasia
33%